Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

EIF4E Antikörper (pSer209) (PE)

Der Maus Monoklonal Anti-EIF4E-Antikörper wurde für ICS validiert. Er ist geeignet, EIF4E in Proben von Human, Ratte und Maus zu detektieren. Es sind 4+ Publikationen verfügbar.
Produktnummer ABIN1177052

Kurzübersicht für EIF4E Antikörper (pSer209) (PE) (ABIN1177052)

Target

Alle EIF4E Antikörper anzeigen
EIF4E (Eukaryotic Translation Initiation Factor 4E (EIF4E))

Reaktivität

  • 126
  • 64
  • 52
  • 19
  • 5
  • 5
  • 5
  • 4
  • 3
  • 3
  • 2
  • 2
  • 2
  • 1
Human, Ratte, Maus

Wirt

  • 109
  • 16
  • 2
Maus

Klonalität

  • 99
  • 28
Monoklonal

Konjugat

  • 61
  • 9
  • 8
  • 6
  • 5
  • 4
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
Dieser EIF4E Antikörper ist konjugiert mit PE

Applikation

  • 100
  • 52
  • 44
  • 28
  • 27
  • 26
  • 16
  • 16
  • 16
  • 14
  • 7
  • 6
  • 2
  • 1
  • 1
Intracellular Staining (ICS)

Klon

J77-925
  • Bindungsspezifität

    • 40
    • 15
    • 8
    • 7
    • 6
    • 5
    • 4
    • 3
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    pSer209

    Marke

    BD Phosflow™

    Aufreinigung

    The monoclonal antibody was purified from tissue culture supernatant or ascites by affinity chromatography.

    Immunogen

    Phosphorylated Human eIF4E Peptide

    Isotyp

    IgG1 kappa
  • Applikationshinweise

    Either BD Cytofix™ fixation buffer or BD™ Phosflow Fix Buffer I may be used for cell fixation. Any of the three BD™ Phosflow permeabilization buffers may be used.

    Probenmenge

    20 μL

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Format

    Liquid

    Buffer

    Aqueous buffered solution containing BSA and ≤0.09 % sodium azide.

    Konservierungsmittel

    Sodium azide

    Vorsichtsmaßnahmen

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Lagerung

    4 °C

    Informationen zur Lagerung

    The antibody was conjugated with R-PE under optimum conditions, and unconjugated antibody and free PE were removed. Store undiluted at 4°C and protected from prolonged exposure to light. Do not freeze.
  • Culjkovic, Topisirovic, Borden: "Controlling gene expression through RNA regulons: the role of the eukaryotic translation initiation factor eIF4E." in: Cell cycle (Georgetown, Tex.), Vol. 6, Issue 1, pp. 65-9, (2007) (PubMed).

    Wendel, Silva, Malina, Mills, Zhu, Ueda, Watanabe-Fukunaga, Fukunaga, Teruya-Feldstein, Pelletier, Lowe: "Dissecting eIF4E action in tumorigenesis." in: Genes & development, Vol. 21, Issue 24, pp. 3232-7, (2007) (PubMed).

    Grolleau, Kaplan, Hanash, Beretta, Richardson: "Impaired translational response and increased protein kinase PKR expression in T cells from lupus patients." in: The Journal of clinical investigation, Vol. 106, Issue 12, pp. 1561-8, (2001) (PubMed).

    Waskiewicz, Flynn, Proud, Cooper: "Mitogen-activated protein kinases activate the serine/threonine kinases Mnk1 and Mnk2." in: The EMBO journal, Vol. 16, Issue 8, pp. 1909-20, (1997) (PubMed).

  • Target

    EIF4E (Eukaryotic Translation Initiation Factor 4E (EIF4E))

    Hintergrund

    The eukaryotic translation Initiation Factor 4E (eIF4E) is a 25-kDa phosphoprotein that specifically binds to the 7-methylguanosine-containing cap of mRNA. eIF4E is the rate-limiting component for the initiation of cap-dependent translation by the eIF4F translation initiation complex, which is composed of eIF4E, eIF4G, and eIF4A. This complex promotes the unwinding of secondary structure at the 5' untranslated region of mRNA that is necessary to expose and locate the AUG initiation codon. Other functions of eIF4E have been identified, such as promoting the export of mRNAs that are involved in cell cycle progression from the nucleus and differentially regulating the translation of certain mRNAs in the cytoplasm. Three mechanisms for eIF4E regulation have been identified: Mnk1-mediated phosphorylation on serine 209 (S209) is required for eIF4E binding to the cap structure, over-expression of phosphorylated eIF4E can lead to increased cell proliferation, suppression of apoptosis, and a transformed phenotype, and interactions with nonphosphorylated eIF4E-binding proteins inhibit the formation of the eIF4F complex. The J77-925 monoclonal antibody recognizes the phosphorylated S209 (pS209) of eIF4E.
    Synonyms: eIF-4E, CBP, EIF4E1, EIF4EL1, EIF4F, mRNA cap-binding protein

    Pathways

    BCR Signaling
Sie sind hier:
Chat with us!